Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeTo |
Diet and exercise
|
| gptkbp:approvedBy |
1920s
|
| gptkbp:category |
Antidiabetic medication
|
| gptkbp:cause |
Allergic reactions
|
| gptkbp:contraindication |
gptkb:liver_disease
Severe renal impairment |
| gptkbp:includes |
gptkb:Sulfonylureas
gptkb:Insulin gptkb:DPP-4_inhibitors gptkb:GLP-1_receptor_agonists gptkb:SGLT2_inhibitors Biguanides Meglitinides Thiazolidinediones |
| gptkbp:interactsWith |
gptkb:beer
Beta blockers Corticosteroids Diuretics |
| gptkbp:mechanismOfAction |
Lower blood glucose levels
|
| gptkbp:monitors |
Blood glucose testing
|
| gptkbp:prescribes |
gptkb:Primary_care_physician
Endocrinologist |
| gptkbp:regulates |
Blood sugar
|
| gptkbp:routeOfAdministration |
gptkb:Oral
Subcutaneous |
| gptkbp:sideEffect |
Weight gain
Hypoglycemia Gastrointestinal upset |
| gptkbp:usedFor |
gptkb:Diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:D003371
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hypoglycemic Agents
|